United Therapeutics Corp (UTHR)

02:41 AM

Published on: 2025-08-27 13:41:12 - Newser

02:41 AM

02:06 AM

Using flow based indicators on United Therapeutics CorporationWeekly Loss Report & Weekly High Return Forecasts - Newser

02:06 AM

12:40 PM

How hedge fund analytics apply to United Therapeutics Corporation stockMarket Activity Report & Daily Profit Focused Screening - Newser

12:40 PM

10:42 AM

MannKind rises as United Therapeutics expands deal (MNKD) - Seeking Alpha

10:42 AM

10:05 AM

Leading vs lagging indicators on United Therapeutics Corporation performanceDollar Strength & Capital Efficiency Focused Ideas - Newser

10:05 AM

08:31 AM

MannKind Amends License Agreement with United Therapeutics - TipRanks

08:31 AM

08:27 AM

United Therapeutics expands partnership with MannKind for new therapy - Investing.com

08:27 AM

08:17 AM

MannKind expands collaboration with United Therapeutics, receives $5 million upfront - Investing.com

08:17 AM

08:12 AM

MannKind Corporation Collaborates with United Therapeutics to Develop Second Dry Powder Inhalation Therapy - Quiver Quantitative

08:12 AM

08:05 AM

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy - uk.finance.yahoo.com

08:05 AM

03:02 AM

How to monitor United Therapeutics Corporation with trend dashboards2025 Fundamental Recap & Consistent Profit Alerts - Newser

03:02 AM

Aug 26, 2025

United Therapeutics Corporation stock trend forecastTrade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser

Aug 26, 2025

Aug 26, 2025

Momentum divergence signals in United Therapeutics Corporation chartQuarterly Earnings Report & High Accuracy Trade Alerts - Newser

Aug 26, 2025

Aug 26, 2025

Published on: 2025-08-26 12:14:12 - Newser

Aug 26, 2025

Aug 26, 2025

What’s next for United Therapeutics Corporation stock priceBear Alert & Low Drawdown Momentum Trade Ideas - Newser

Aug 26, 2025

Aug 26, 2025

Published on: 2025-08-26 11:15:14 - Newser

Aug 26, 2025

Aug 25, 2025

How to build a dashboard for United Therapeutics Corporation stockInsider Buying & Expert Verified Stock Movement Alerts - Newser

Aug 25, 2025

Aug 25, 2025

Historical volatility pattern of United Therapeutics Corporation visualizedWeekly Gains Summary & Weekly Breakout Stock Alerts - Newser

Aug 25, 2025

Aug 23, 2025

Detecting price anomalies in United Therapeutics Corporation with AIWeekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser

Aug 23, 2025

Aug 23, 2025

Published on: 2025-08-23 04:09:17 - Newser

Aug 23, 2025

Aug 22, 2025

Can United Therapeutics Corporation hit a new high this monthJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser

Aug 22, 2025

Aug 19, 2025

United Therapeutics stock holds Buy rating at UBS on Tyvaso prospects - Investing.com Nigeria

Aug 19, 2025

Aug 19, 2025

Order flow analysis tools used on United Therapeutics Corporation2025 Technical Patterns & Long-Term Growth Portfolio Plans - Newser

Aug 19, 2025

Aug 16, 2025

Key resistance and support levels for United Therapeutics CorporationEarnings Summary Report & Reliable Intraday Trade Alerts - Newser

Aug 16, 2025

Aug 15, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis - MSN

Aug 15, 2025

Aug 14, 2025

United Therapeutics stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com

Aug 14, 2025

Aug 13, 2025

United Therapeutics stock price target raised to $415 from $385 at UBS - Investing.com

Aug 13, 2025

Aug 13, 2025

United Therapeutics stock price target raised to $415 from $385 at UBS By Investing.com - Investing.com South Africa

Aug 13, 2025

Aug 12, 2025

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Aug 12, 2025

Aug 09, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: A Potential Game-Changer - The Globe and Mail

Aug 09, 2025

Aug 08, 2025

Pfizer’s Inclacumab Study: Long-term Safety Insights for Sickle Cell Disease - The Globe and Mail

Aug 08, 2025

Aug 08, 2025

Should You Be Adding United Therapeutics (NASDAQ:UTHR) To Your Watchlist Today? - 富途牛牛

Aug 08, 2025

Aug 07, 2025

United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment - TipRanks

Aug 07, 2025

Aug 06, 2025

MannKind (MNKD) Q2 Revenue Rises 6% - The Motley Fool

Aug 06, 2025

Aug 04, 2025

H.C. Wainwright Lowers PT on United Therapeutics Corporation (UTHR) to $400 From $425, Keeps a Buy Rating - Insider Monkey

Aug 04, 2025

Aug 01, 2025

United Therapeutics Announces $1B Accelerated Share Repurchase Program. - AInvest

Aug 01, 2025

Aug 01, 2025

United Therapeutics Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

Aug 01, 2025

Aug 01, 2025

United Therapeutics’ PAH Study Update: Implications for Investors - TipRanks

Aug 01, 2025

Aug 01, 2025

United Therapeutics Advances in Pulmonary Fibrosis Treatment with Phase 3 Study - TipRanks

Aug 01, 2025

Aug 01, 2025

United Therapeutics (UTHR) Launches $1B Stock Buyback Program - GuruFocus

Aug 01, 2025

Aug 01, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 01, 2025

Aug 01, 2025

United Therapeutics stock jumps on $1 billion share repurchase plan - Investing.com

Aug 01, 2025